MILYNVO Trademark

Trademark Overview


On Tuesday, January 23, 2024, a trademark application was filed for MILYNVO with the United States Patent and Trademark Office. The USPTO has given the MILYNVO trademark a serial number of 98371993. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Sunday, December 15, 2024. This trademark is owned by Laminar Pharmaceuticals S. A.. The MILYNVO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical compositions, namely, preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Pharmaceutical drugs, namely, preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neu...

Applicators for medications, namely, syringes, nebulizers, spoons for administering medicine and medicinal catheters; Receptacles for applying medicines, namely, powder and liquid mixer cups for dispensing medicine, dosage dispensers for administering medicine to patients, dropper bottles for administering medication, sold empty and medicine dispensing kit comprised primarily of powder and liquid mixer cups for dispensing medicine and a dosage dispenser for administering medicine to patients; Injection devices for pharmaceuticals; Drug delivery devices sold empty, namely, syringes and infusion sets; Diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, cancer cells, DNA, RNA, and body fluids; tools for medical diagnostics, namely, medical diagnostic instruments for testing blood sugar levels, cancer cells, DNA, RNA, and body fluids; Medical diagnostic apparatus for measuring blood sugar levels, cancer cells, DNA, RNA, and body fluids; Di...

General Information


Serial Number98371993
Word MarkMILYNVO
Filing DateTuesday, January 23, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateSunday, December 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "MILYNVO" with an array of dots arranged in a wave shape above the letter "O" and extending to the right of the letter "O" with smaller dots being disposed in a central part of the array and larger dots at opposite left and right ends of the array.
Goods and ServicesPharmaceutical compositions, namely, preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Pharmaceutical drugs, namely, preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Medicines for human purposes for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Medicines for veterinary purposes for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Pomades for medical purposes; Skin care preparations for medical use; Pharmaceutical preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Herbal preparations for medical use; Nutraceutical preparations for therapeutic or medical purposes; Medicinal preparations and diagnostic substances for medical purposes; Pharmaceutical preparations and diagnostic substances for medical purposes; Veterinary preparations and diagnostic substances for medical purposes; Dietary supplements and dietetic preparations adapted for medical purposes; Natural remedies preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Greases for medical or veterinary purposes; Animal fodder additives in the nature of acidifiers and enzymes for medical purposes; Additives in the nature of dietary supplements for animals; Dietary supplements for animals; Dietary supplements for human beings; Cardiovascular agents for medical purposes; Cellular function activating agents for medical purposes; Cachets for medicinal purposes, namely, antivirals and capsules for pharmaceutical purposes; Biological preparations for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Bacteriological preparations for medical and veterinary use; Biochemical preparations for medical use, namely, bioengineered membranes for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Biochemical preparations for veterinary use, namely, bioengineered membranes for the treatment of cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Reagents for medical use; Diagnostic preparations for medical or veterinary purposes; Biological reagents for medical use; Clinical medical reagents; Medical diagnostic reagents for the analysis of body fluids; Reagents for veterinary purposes for the analysis of body fluids; Diagnostic reagents for medical or veterinary purposes; Medical diagnostic reactants for medical diagnosis of disease; Reagents for use in diagnostic tests for medical purposes; Pharmaceutical compounds for treating cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmacological preparations for skincare; Pharmaceutical preparations for the treatment of disorders of the metabolic system; Pharmaceutical preparations for the treatment of diseases of the nervous system; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical agents for treating physically caused lesions; Probiotic, vitamin and mineral preparations in powder form, for medical use; Diagnostic and analytical kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis, for medical use or for veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of human and animal bodily fluids for medical purposes or for veterinary purposes; Diagnostic and analytical kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic kits comprised primarily of medical diagnostic reagents, for medical use; Diagnostic kits comprised primarily of chemical reagent preparations for medical or veterinary use; Diagnostic test kits for medical diagnosis purposes consisting primarily of reagents for use in detecting diseases in humans and animals.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesApplicators for medications, namely, syringes, nebulizers, spoons for administering medicine and medicinal catheters; Receptacles for applying medicines, namely, powder and liquid mixer cups for dispensing medicine, dosage dispensers for administering medicine to patients, dropper bottles for administering medication, sold empty and medicine dispensing kit comprised primarily of powder and liquid mixer cups for dispensing medicine and a dosage dispenser for administering medicine to patients; Injection devices for pharmaceuticals; Drug delivery devices sold empty, namely, syringes and infusion sets; Diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, cancer cells, DNA, RNA, and body fluids; tools for medical diagnostics, namely, medical diagnostic instruments for testing blood sugar levels, cancer cells, DNA, RNA, and body fluids; Medical diagnostic apparatus for measuring blood sugar levels, cancer cells, DNA, RNA, and body fluids; Diagnostic apparatus for use in medical procedures for testing blood sugar levels, cancer cells, DNA, RNA, and body fluids; Testing apparatus for medical purposes; Test probe assemblies for medical use; Test probes for medical use; Testing instruments for medical diagnostic purposes, namely, for blood sugar levels, cancer cells, DNA, RNA, and body fluids; Testing probes for medical diagnostic purposes, namely, probes for cancer, vascular pathologies, obesity, hypertension, cutaneous pathologies, metabolic pathologies, cardiovascular diseases, inflammatory diseases, systemic diseases, respiratory diseases, infectious pathologies, nerve fibre lesions, neurodegenerative pathologies, including Alzheimer, neuroregeneration, neurological diseases, neuropathic pain, paralysis, sleep disorders, digestive pathologies, musculoskeletal and connective tissue diseases, genitourinary pathologies, hypercholesterolemia, hypertriglyceridemia and cystic fibrosis; Medical and diagnostic medical instrument kits for medical diagnosis purposes consisting primarily of probes, buffers and reagents for use in microbial testing.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLaminar Pharmaceuticals S. A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalma de Mallorca (Isl E-07121
ES

Trademark Events


Event DateEvent Description
Friday, May 24, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 23, 2024NEW APPLICATION ENTERED
Friday, May 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 3, 2024NON-FINAL ACTION E-MAILED
Monday, August 19, 2024ASSIGNED TO EXAMINER
Thursday, October 3, 2024NON-FINAL ACTION WRITTEN
Thursday, October 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED